Achieve Life Sciences Statistics
NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
5.56-0.31 (-5.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Achieve Life Sciences by the numbers
Achieve Life Sciences has a market capitalization of $573.2 million based on 103.10M shares outstanding. With trailing EPS of $-1.71, Achieve Life Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.1% below its 50-day average and 3.4% below its 200-day average.
Average daily trading volume is 1.38M shares, or about $7.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
QUIT valuation vs. peer median
| Metric | QUIT | Peer median | Difference |
|---|---|---|---|
| Market cap | $573.25M | $122.50M | +368% |
| Avg. volume | 1.38M | 349.60K | +295% |
Peer median across 8 companies: QDEL, MYGN, TKNO, NNNN, ICCC, IMDX, VNRX, TRIB.
Valuation
- Market cap
- $573.25M
- EPS (TTM)
- $-1.71
- Shares outstanding
- 103.10M
Price and trading
- Previous close
- 5.87
- Open
- 5.71
- Day range
- 5.50 – 5.97
- 52-week range
- 2.62 – 8.64
- Beta
- —
- Volume
- 1.92M
- Average volume
- 1.38M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 26, 2026
Additional statistics
- Market Cap
- 573.25M
- Forward Pe
- -8.13
- Eps
- -1.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.64
- Week52 Low
- 2.62
- Avg Volume
- 1.38M
- Shares Outstanding
- 103.10M
- Ma50
- 6.96
- Ma200
- 5.75
- Earnings Date
- Nov 26, 2026
- Pct From52w High
- -35.65%
- Pct From52w Low
- 112.21%